# Abzena: Moving medicine forward\.

> Abzena is a fully integrated biopharmaceutical CDMO\+CRO for antibodies, ADCs, AOCs, RDCs, vaccines, from discovery thru commercial\.

Generated by Yoast SEO v28.4, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [Ask Abzena](https://abzena.com/about/ask-abzena/)
- [Privacy Policy](https://abzena.com/privacy-policy/)
- [Careers](https://abzena.com/careers/)
- [Internships](https://abzena.com/careers/internships/)
- [Awards \& Achievements](https://abzena.com/about/awards-achievements/)

## Services
- [Mammalian Cell Line Development](https://abzena.com/biologics/cell-line-development/): Achieve stable pools in 3 weeks, accelerate from DNA to RCB in just 10 weeks and GMP in 6 months with our industry\-leading mammalian cell line development services\.
- [ThioBridge®: Linking Antibody\-to\-Drug with ThioBridge® Conjugation Technology for Better ADCs \& AOCs](https://abzena.com/solutions/thiobridge/): Enhance your ADC \& AOC design \& delivery development with our ThioBridge® conjugation platform technology\.
- [Antibody\-Oligonucleotide Conjugates \(AOCs\)](https://abzena.com/biologics/bioconjugates-and-adcs/antibody-oligonucleotide-conjugates-aocs/): We are global leaders in the development of antibody\-oligonucleotide conjugates \(AOCs\)\.
- [Antibody\-Oligonucleotide Conjugate \(AOC\) Manufacturing](https://abzena.com/biologics/bioconjugates-and-adcs/antibody-oligonucleotide-conjugates-aocs/aoc-manufacturing/): Coupling two decades of bioconjugation know\-how with deep oligo chemistry expertise to streamline AOC development\.
- [Oncology CDMO \+ CRO Development \& Manufacturing Services](https://abzena.com/biologics/oncology-cdmo-cro/): Accelerate your path to market with our advanced, integrated biologics CDMO \+ CRO services \& solutions that move medicine forward\.

## Events
- [Festival of Biologics EU 2026](https://abzena.com/event/festival-of-biologics-eu-2026/)
- [CPHI Milan 2026](https://abzena.com/event/cphi-milan-2026/)
- [TKS: Antibody\-Drug Conjugates Symposium](https://abzena.com/event/tks-antibody-drug-conjugates-symposium/)
- [Seattle Multiomics Mixer](https://abzena.com/event/seattle-multiomics-mixer/)
- [PEGs Europe 2026](https://abzena.com/event/pegs-europe-2026/)

## Team
- [Troy Wright](https://abzena.com/about/leadership-team/troy-wright/)
- [Thomas Cornell](https://abzena.com/about/leadership-team/thomas-cornell/)
- [Tatyana Touzova](https://abzena.com/about/leadership-team/tatyana-touzova/)
- [Campbell Bunce](https://abzena.com/about/leadership-team/campbell-bunce/)
- [Peter Gray](https://abzena.com/about/leadership-team/peter-gray/)

## Resources
- [B Cell Antibody Discovery \- ANTI\-PD1 Case Study](https://abzena.com/resources/case-studies/b-cell-antibody-discovery-anti-pd1-case-study/)
- [Scientific Poster: Application of Real\-Time Live Cell Imaging in the Development of Antibody\-Drug Conjugates](https://abzena.com/resources/scientific-posters-and-publications/application-of-real-time-live-cell-imaging-in-the-development-of-antibody-drug-conjugates/)
- [Leveraging Analytics to Ensure Stable \& Scalable Cell Lines](https://abzena.com/resources/webinars-and-videos/leveraging-analytics-to-ensure-stable-scalable-cell-lines/)
- [Optimal Formulation Development](https://abzena.com/resources/webinars-and-videos/optimal-formulation-development/)
- [Cell Line Development: An Overview of the Linchpin in Successful Biotherapeutic Development](https://abzena.com/resources/whitepapers/an-overview-of-cell-line-development/): Cell Line Development \(CLD\) is the linchpin of biotherapeutic development and manufacturing\. Discover our CLD whitepaper here today\.

## News Articles
- [The Pharma Letter: Why ADC development needs a new level of bioconjugation expertise](https://abzena.com/articles/feature-articles/the-pharma-letter-why-adc-development-needs-new-level-of-bioconjugation-expertise/)
- [24/7 BioPharma: Changing expectations in development and manufacturing](https://abzena.com/articles/feature-articles/24-7-biopharma-changing-expectations-in-development-and-manufacturing/)
- [PharmTech: Strategies to Maximize Stability of Emerging Biologics](https://abzena.com/articles/feature-articles/pharmtech-strategies-to-maximize-stability-of-emerging-biologics/)
- [Pharma Source: ADCs vs\. AOCs \- Shared Design Principles \& Key Differences in Bioconjugate Engineering](https://abzena.com/articles/feature-articles/pharma-source-adcs-vs-aocs-shared-design-principles-key-differences-in-bioconjugate-engineering/)
- [PharmaSource Podcast: Abzena on AOCs \- Building US Capacity to Compete With China](https://abzena.com/articles/feature-articles/pharmasource-podcast-abzena-on-aocs-building-us-capacity-to-compete-with-china/)

## History
- [2023](https://abzena.com/history/2023-2/)
- [2022](https://abzena.com/history/2022-2/)
- [2013](https://abzena.com/history/2013-2/)
- [2025](https://abzena.com/history/2025-2/)
- [2024](https://abzena.com/history/2024-2/)

## Facilities
- [Cambridge, UK](https://abzena.com/about/locations/cambridge-uk/): Abzena Cambridge specializes in the early discovery, design, and development of complex biologics and bioconjugates\.
- [Bristol, PA, USA](https://abzena.com/about/locations/bristol-usa/): At Abzena Bristol, we specialize in bioconjugation, quality linker payloads, highly potent materials and complex chemistry\.
- [Raleigh, NC, USA](https://abzena.com/about/locations/raleigh-nc-usa/): At Abzena Bristol, we specialize in bioconjugation, quality linker payloads, highly potent materials and complex chemistry\.
- [San Diego, CA, USA](https://abzena.com/about/locations/san-diego-usa/): Abzena San Diego boasts a trio of cutting\-edge facilities designed to accelerate the development, production, and testing of biologics\.  

## Content type
- [Webinars \& Videos](https://abzena.com/resources/webinars-and-videos/)
- [Scientific Posters \& Publications](https://abzena.com/resources/scientific-posters-and-publications/)
- [Info Sheets](https://abzena.com/resources/info-sheets/)
- [Case Studies](https://abzena.com/resources/case-studies/)
- [Whitepapers](https://abzena.com/resources/whitepapers/)

## Content Type
- [Articles](https://abzena.com/articles/feature-articles/)
- [News](https://abzena.com/articles/news/)
- [Blog](https://abzena.com/articles/blog/)

## Facility Service
- [Manufacturing](https://abzena.com/tax-facility-service/manufacturing/)
- [Discovery](https://abzena.com/tax-facility-service/discovery/)
- [Development](https://abzena.com/tax-facility-service/development/)

## Optional
- [Sitemap index](https://abzena.com/sitemap_index.xml)